Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Gourley

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancerOlusola O Faluyi, Charlie Gourley, John F Smyth, et al.
Cancers|June 13, 2020
Identifying and Overcoming Mechanisms of PARP Inhibitor Resistance in Homologous Recombination Repair-Deficient and Repair-Proficient High Grade Serous Ovarian Cancer CellsMiriam K Gomez, Giuditta Illuzzi, Carlota Colomer, et al.
Gynecologic Oncology|September 10, 2019
Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinomaRobert L Hollis, Barbara Stanley, Yasushi Iida, et al.
BMC Cancer|December 21, 2014
A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocolShibani Nicum, Corran Roberts, Lucy Boyle, et al.
Journal of Psychosomatic Research|September 10, 2020
Different independent associations of depression and anxiety with survival in patients with cancerJane Walker, Nicholas Magill, Amy Mulick, et al.
Gynecologic Oncology Reports|October 27, 2022
Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases?Dominique Barnes, Nissreen Mohammad, Lien Hoang, et al.
BMC Cancer|June 6, 2018
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatmentChrysi Xintaropoulou, Carol Ward, Alan Wise, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancerDavid S P Tan, Timothy A Yap, Margaret Hutka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2024
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and EuropeKathleen N Moore, Mansoor R Mirza, Charlie Gourley, et al.
Psychosomatic Medicine|May 3, 2021
Major Depression and Survival in People With CancerJane Walker, Amy Mulick, Nicholas Magill, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancerOlusola O Faluyi, Charlie Gourley, John F Smyth, et al.
Cancers|June 13, 2020
Identifying and Overcoming Mechanisms of PARP Inhibitor Resistance in Homologous Recombination Repair-Deficient and Repair-Proficient High Grade Serous Ovarian Cancer CellsMiriam K Gomez, Giuditta Illuzzi, Carlota Colomer, et al.
Gynecologic Oncology|September 10, 2019
Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinomaRobert L Hollis, Barbara Stanley, Yasushi Iida, et al.
BMC Cancer|December 21, 2014
A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocolShibani Nicum, Corran Roberts, Lucy Boyle, et al.
Journal of Psychosomatic Research|September 10, 2020
Different independent associations of depression and anxiety with survival in patients with cancerJane Walker, Nicholas Magill, Amy Mulick, et al.
Gynecologic Oncology Reports|October 27, 2022
Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases?Dominique Barnes, Nissreen Mohammad, Lien Hoang, et al.
BMC Cancer|June 6, 2018
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatmentChrysi Xintaropoulou, Carol Ward, Alan Wise, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancerDavid S P Tan, Timothy A Yap, Margaret Hutka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2024
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and EuropeKathleen N Moore, Mansoor R Mirza, Charlie Gourley, et al.
Psychosomatic Medicine|May 3, 2021
Major Depression and Survival in People With CancerJane Walker, Amy Mulick, Nicholas Magill, et al.
Pageof 15